Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
|
|
NeuBase Therapeutics, Inc. (OHRP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/27/2023 |
SC 13G/A
| Kershner Trading Americas,LLC reports a 4.5% stake in NeuBase Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Greenlight Capital reports a 8.3% stake in NeuBase Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/29/2020 |
SC 13G/A
| Kershner Trading Americas,LLC reports a 5.8% stake in Neubase Therapeutics, LLC |
| 05/01/2020 |
SC 13G/A
| HIRSCHMAN ORIN reports a 2.4% stake in NEUBASE THERAPEUTICS, INC . --------------------------------------------------------------------------------- |
| 02/15/2018 |
SC 13G/A
| HIRSCHMAN ORIN reports a 5.1% stake in OHR PHARMACEUTICAL, INC. |
| 02/14/2017 |
SC 13G/A
| HIRSCHMAN ORIN reports a 7.7% stake in OHR PHARMACEUTICAL, INC . |
| 02/16/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2016 |
SC 13G/A
| HIRSCHMAN ORIN reports a 9% stake in OHR PHARMACEUTICAL, INC . |
| 02/13/2015 |
SC 13G/A
| Visium Asset Management, LP reports a 4.1% stake in Ohr Pharmaceutical, Inc. |
| 02/21/2014 |
SC 13G/A
| ALPERT CHARLES reports a 4.9% stake in Ohr Pharmaceutical Inc. |
| 02/14/2014 |
SC 13G/A
| PACKER PAUL reports a 6.6% stake in OHR PHARMACEUTICAL, INC. |
|
|